Suppr超能文献

胚胎期结节下丘脑少突胶质细胞的发育及Ascl1的影响

Oligodendrocyte development in the embryonic tuberal hypothalamus and the influence of Ascl1.

作者信息

Marsters Candace M, Rosin Jessica M, Thornton Hayley F, Aslanpour Shaghayegh, Klenin Natasha, Wilkinson Grey, Schuurmans Carol, Pittman Quentin J, Kurrasch Deborah M

机构信息

Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.

Department of Pharmacology & Physiology, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.

出版信息

Neural Dev. 2016 Nov 18;11(1):20. doi: 10.1186/s13064-016-0075-9.

Abstract

BACKGROUND

Although the vast majority of cells in our brains are glia, we are only beginning to understand programs governing their development, especially within the embryonic hypothalamus. In mice, gliogenesis is a protracted process that begins during embryonic stages and continues into the early postnatal period, with glial progenitors first producing oligodendrocyte precursor cells, which then differentiate into pro-oligodendrocytes, pro-myelinating oligodendrocytes, and finally, mature myelinating oligodendrocytes. The exact timing of the transition from neurogenesis to gliogenesis and the subsequent differentiation of glial lineages remains unknown for most of the Central Nervous System (CNS), and is especially true for the hypothalamus.

METHODS

Here we used mouse embryonic brain samples to determine the onset of gliogenesis and expansion of glial populations in the tuberal hypothalamus using glial markers Sox9, Sox10, Olig2, PdgfRα, Aldh1L1, and MBP. We further employed Ascl1 and Neurog2 mutant mice to probe the influence of these proneual genes on developing embryonic gliogenic populations.

RESULTS

Using marker analyses for glial precursors, we found that gliogenesis commences just prior to E13.5 in the tuberal hypothalamus, beginning with the detection of glioblast and oligodendrocyte precursor cell markers in a restricted domain adjacent to the third ventricle. Sox9+ and Olig2+ glioblasts are also observed in the mantle region from E13.5 onwards, many of which are Ki67+ proliferating cells, and peaks at E17.5. Using Ascl1 and Neurog2 mutant mice to investigate the influence of these bHLH transcription factors on the progression of gliogenesis in the tuberal hypothalamus, we found that the elimination of Ascl1 resulted in an increase in oligodendrocyte cells throughout the expansive period of oligodendrogenesis.

CONCLUSION

Our results are the first to define the timing of gliogenesis in the tuberal hypothalamus and indicate that Ascl1 is required to repress oligodendrocyte differentiation within this brain region.

摘要

背景

尽管我们大脑中的绝大多数细胞是神经胶质细胞,但我们才刚刚开始了解控制其发育的程序,尤其是在胚胎下丘脑内。在小鼠中,神经胶质细胞生成是一个漫长的过程,始于胚胎期并持续到出生后早期,神经胶质祖细胞首先产生少突胶质前体细胞,然后分化为前少突胶质细胞、前髓鞘形成少突胶质细胞,最后是成熟的髓鞘形成少突胶质细胞。对于大多数中枢神经系统(CNS)来说,从神经发生向神经胶质细胞生成转变的确切时间以及随后神经胶质谱系的分化仍然未知,下丘脑尤其如此。

方法

在这里,我们使用小鼠胚胎脑样本,通过神经胶质细胞标志物Sox9、Sox10、Olig2、PdgfRα、Aldh1L1和MBP来确定结节下丘脑神经胶质细胞生成的起始和神经胶质细胞群体的扩张。我们进一步利用Ascl1和Neurog2突变小鼠来探究这些神经前体基因对发育中的胚胎神经胶质细胞生成群体的影响。

结果

通过对神经胶质前体的标志物分析,我们发现结节下丘脑的神经胶质细胞生成在E13.5之前开始,首先在与第三脑室相邻的受限区域检测到成胶质细胞和少突胶质前体细胞标志物。从E13.5开始,在套层区域也观察到Sox9+和成胶质细胞Olig2+,其中许多是Ki67+增殖细胞,并在E17.5达到峰值。利用Ascl1和Neurog2突变小鼠来研究这些bHLH转录因子对结节下丘脑神经胶质细胞生成进程的影响,我们发现Ascl1的缺失导致在整个少突胶质细胞生成的扩张期少突胶质细胞数量增加。

结论

我们的结果首次确定了结节下丘脑神经胶质细胞生成的时间,并表明Ascl1是抑制该脑区少突胶质细胞分化所必需的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验